Sergei Agoulnik
- Cancer Research top 5%
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 2
- Oncology top 10%
- Cancer Treatment and Pharmacology 4
- Cancer-related Molecular Pathways 3
- Cancer Cells and Metastasis 2
-
- Glycosylation and Glycoproteins Research 2
- Circular RNAs in diseases 2
-
- Microtubule and mitosis dynamics 2
- Co-authors
- Yoshiya OdaZoltán DezsőYasuhiro FunahashiJudy OestreicherMichael ByrneKen AoshimaFrançois P. BernierGalina Kuznetsov
- Partner nations
- United StatesJapanSwitzerland
In The Last Decade
Sergei Agoulnik
15 papers receiving 880 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 332
- Oncology 348
- Molecular Biology 438
- Biotechnology 41
- Pulmonary and Respiratory Medicine 147
Countries citing papers authored by Sergei Agoulnik
This map shows the geographic impact of Sergei Agoulnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergei Agoulnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergei Agoulnik more than expected).
Fields of papers citing papers by Sergei Agoulnik
This network shows the impact of papers produced by Sergei Agoulnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergei Agoulnik. The network helps show where Sergei Agoulnik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sergei Agoulnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2016 | 55 | |
| 3 | 2016 | 0 | |
| 4 | 2015 | 1 | |
| 5 | 2014 | 50 | |
| 6 | 2014 | 33 | |
| 7 | 2014 | 284 | |
| 8 | 2013 | 2 | |
| 9 | 2013 | 306 | |
| 10 | 2013 | 1 | |
| 11 | 2013 | 23 | |
| 12 | 2013 | 1 | |
| 13 | 2011 | 44 | |
| 14 | 2009 | 85 | |
| 15 | Abstract #3687: In vivo anticancer activity of E6201, a novel MEK1 inhibitor, against BRAF-mutated human cancer xenografts | 2009 | 3 |
| 16 | 2005 | 9 |
About Sergei Agoulnik
Sergei Agoulnik is a scholar working on Cancer Research, Oncology and Cell Biology, having authored 16 papers that have together received 898 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), MicroRNA in disease regulation (3 papers), Cancer-related Molecular Pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Microtubule and mitosis dynamics (2 papers), Cancer Cells and Metastasis (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (332 citations), Oncology (348 citations) and Molecular Biology (438 citations). Sergei Agoulnik has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Yoshiya Oda, Zoltán Dezső, Yasuhiro Funahashi, Judy Oestreicher, Michael Byrne, Ken Aoshima, François P. Bernier, Galina Kuznetsov, Pavan Kumar and Mamoru Yanagimachi. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.